Rami Z Morsi, Mohamed Elfil, Hazem S Ghaith, Mohammad Aladawi, Ahmad Elmashad, Sachin Kothari, Harsh Desai, Shyam Prabhakaran, Fawaz Al-Mufti, Tareq Kass-Hout
{"title":"Endovascular Thrombectomy for Large Ischemic Strokes: A Living Systematic Review and Meta-Analysis of Randomized Trials.","authors":"Rami Z Morsi, Mohamed Elfil, Hazem S Ghaith, Mohammad Aladawi, Ahmad Elmashad, Sachin Kothari, Harsh Desai, Shyam Prabhakaran, Fawaz Al-Mufti, Tareq Kass-Hout","doi":"10.5853/jos.2023.00752","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>New studies have shown that endovascular thrombectomy (EVT) is safe and effective for acute ischemic stroke (AIS) patients with large ischemic areas. The aim of our study is to conduct a living systematic review and meta-analysis of randomized trials comparing EVT versus medical management only.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, and the Cochrane Library to identify randomized controlled trials (RCTs) comparing EVT versus medical management alone in AIS patients with large ischemic regions. We conducted our meta-analysis using fixed-effect models to compare functional independence, mortality, and symptomatic intracranial hemorrhage (sICH) between EVT and standard medical management only. We assessed the risk of bias using the Cochrane risk-of-bias tool and the certainty of evidence for each outcome using the Grading of Recommendations, Assessment, Development, and Evaluations approach.</p><p><strong>Results: </strong>Of 14,513 citations, we included 3 RCTs with a total of 1,010 participants. We found low-certainty evidence of possibly a large increase in the proportion of patients with functional independence (risk difference [RD] 30.3%, 95% CI 15.0% to 52.3%), low-certainty evidence of possibly a small non-significant decrease in mortality (RD -0.7%, 95% CI -3.8% to 3.5%), and low-certainty evidence of possibly a small non-significant increase in sICH (RD 3.1%, 95% CI -0.3% to 9.8%) for AIS patients with large infarcts who underwent EVT compared to medical management only.</p><p><strong>Conclusion: </strong>Low-certainty evidence shows that there is possibly a large increase in functional independence, a small non-significant decrease in mortality, and a small non-significant increase in sICH amongst AIS patients with large infarcts undergoing EVT compared to medical management only.</p>","PeriodicalId":17135,"journal":{"name":"Journal of Stroke","volume":"25 2","pages":"214-222"},"PeriodicalIF":6.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/70/db/jos-2023-00752.PMC10250873.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5853/jos.2023.00752","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 2
Abstract
Background and purpose: New studies have shown that endovascular thrombectomy (EVT) is safe and effective for acute ischemic stroke (AIS) patients with large ischemic areas. The aim of our study is to conduct a living systematic review and meta-analysis of randomized trials comparing EVT versus medical management only.
Methods: We searched MEDLINE, Embase, and the Cochrane Library to identify randomized controlled trials (RCTs) comparing EVT versus medical management alone in AIS patients with large ischemic regions. We conducted our meta-analysis using fixed-effect models to compare functional independence, mortality, and symptomatic intracranial hemorrhage (sICH) between EVT and standard medical management only. We assessed the risk of bias using the Cochrane risk-of-bias tool and the certainty of evidence for each outcome using the Grading of Recommendations, Assessment, Development, and Evaluations approach.
Results: Of 14,513 citations, we included 3 RCTs with a total of 1,010 participants. We found low-certainty evidence of possibly a large increase in the proportion of patients with functional independence (risk difference [RD] 30.3%, 95% CI 15.0% to 52.3%), low-certainty evidence of possibly a small non-significant decrease in mortality (RD -0.7%, 95% CI -3.8% to 3.5%), and low-certainty evidence of possibly a small non-significant increase in sICH (RD 3.1%, 95% CI -0.3% to 9.8%) for AIS patients with large infarcts who underwent EVT compared to medical management only.
Conclusion: Low-certainty evidence shows that there is possibly a large increase in functional independence, a small non-significant decrease in mortality, and a small non-significant increase in sICH amongst AIS patients with large infarcts undergoing EVT compared to medical management only.
背景与目的:新的研究表明,血管内取栓术(EVT)对于大面积缺血的急性缺血性脑卒中(AIS)患者是安全有效的。本研究的目的是对比较EVT与单纯医疗管理的随机试验进行实时系统评价和荟萃分析。方法:我们检索了MEDLINE、Embase和Cochrane图书馆,以确定比较EVT与单独医疗管理在大面积缺血AIS患者中的随机对照试验(rct)。我们使用固定效应模型进行meta分析,比较EVT和标准医疗管理之间的功能独立性、死亡率和症状性颅内出血(sICH)。我们使用Cochrane偏倚风险工具评估偏倚风险,使用推荐、评估、发展和评估分级方法评估每个结果的证据确定性。结果:在14513条引用中,我们纳入了3项随机对照试验,共1010名受试者。我们发现低确定性证据表明功能独立患者比例可能大幅增加(风险差异[RD] 30.3%, 95% CI 15.0%至52.3%),低确定性证据表明死亡率可能小幅非显著降低(RD -0.7%, 95% CI -3.8%至3.5%),低确定性证据表明与仅接受药物治疗相比,接受EVT的AIS大梗死患者siich可能小幅非显著增加(RD 3.1%, 95% CI -0.3%至9.8%)。结论:低确定性证据表明,与仅接受药物治疗相比,接受EVT治疗的大面积梗死AIS患者的功能独立性可能大幅增加,死亡率可能小幅非显著降低,siich可能小幅非显著增加。
Journal of StrokeCLINICAL NEUROLOGYPERIPHERAL VASCULAR DISE-PERIPHERAL VASCULAR DISEASE
CiteScore
11.00
自引率
3.70%
发文量
52
审稿时长
12 weeks
期刊介绍:
The Journal of Stroke (JoS) is a peer-reviewed publication that focuses on clinical and basic investigation of cerebral circulation and associated diseases in stroke-related fields. Its aim is to enhance patient management, education, clinical or experimental research, and professionalism. The journal covers various areas of stroke research, including pathophysiology, risk factors, symptomatology, imaging, treatment, and rehabilitation. Basic science research is included when it provides clinically relevant information. The JoS is particularly interested in studies that highlight characteristics of stroke in the Asian population, as they are underrepresented in the literature.
The JoS had an impact factor of 8.2 in 2022 and aims to provide high-quality research papers to readers while maintaining a strong reputation. It is published three times a year, on the last day of January, May, and September. The online version of the journal is considered the main version as it includes all available content. Supplementary issues are occasionally published.
The journal is indexed in various databases, including SCI(E), Pubmed, PubMed Central, Scopus, KoreaMed, Komci, Synapse, Science Central, Google Scholar, and DOI/Crossref. It is also the official journal of the Korean Stroke Society since 1999, with the abbreviated title J Stroke.